Glassman Wealth Services - SAGE THERAPEUTICS INC ownership

SAGE THERAPEUTICS INC's ticker is SAGE and the CUSIP is 78667J108. A total of 287 filers reported holding SAGE THERAPEUTICS INC in Q3 2019. The put-call ratio across all filers is 1.28 and the average weighting 0.2%.

Quarter-by-quarter ownership
Glassman Wealth Services ownership history of SAGE THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$1,585
-87.8%
77
-74.4%
0.00%
-100.0%
Q4 2021$13,000
+550.0%
301
+514.3%
0.00%
Q3 2021$2,000
-71.4%
49
-61.4%
0.00%
-100.0%
Q2 2021$7,000
-22.2%
127
+1.6%
0.00%
-50.0%
Q1 2021$9,000
-59.1%
125
-50.0%
0.00%
-33.3%
Q4 2020$22,000
+633.3%
250
+455.6%
0.00%
+200.0%
Q3 2020$3,000
+50.0%
450.0%0.00%0.0%
Q2 2020$2,000
+100.0%
45
+95.7%
0.00%
Q1 2020$1,00023
+666.7%
0.00%
Q4 2019$0
-100.0%
3
-66.7%
0.00%
-100.0%
Q2 2019$2,00090.00%
Other shareholders
SAGE THERAPEUTICS INC shareholders Q3 2019
NameSharesValueWeighting ↓
GREAT POINT PARTNERS LLC 1,966,688$120,204,00010.81%
Integral Health Asset Management, LLC 230,000$14,058,0004.30%
Asymmetry Capital Management, L.P. 102,462$6,262,0004.02%
ACUTA CAPITAL PARTNERS, LLC 225,000$13,752,0003.74%
DAFNA Capital Management LLC 158,306$9,676,0003.14%
Bain Capital Life Sciences Investors, LLC 499,100$30,505,0002.84%
Boxer Capital, LLC 1,094,000$66,865,0002.31%
Palo Alto Investors LP 590,200$36,073,0001.98%
Logos Global Management LP 250,000$15,280,0001.96%
Bellevue Group AG 1,579,504$96,539,0001.33%
View complete list of SAGE THERAPEUTICS INC shareholders